• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[异基因骨髓移植受者中粪便微生物群移植治疗难治性艰难梭菌感染合并克罗恩病]

[Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient].

作者信息

Tamura Shinichi, Ishida Hiroyuki, Shimizu Tsunehiro, Imaeda Hirotsugu, Nishida Atsushi, Bamba Shigeki, Andoh Akira, Iwasa Yoko, Kuroda Hiroshi

机构信息

Department of Pediatrics, Kyoto City Hospital.

Department of Infectious Diseases, Kyoto City Hospital.

出版信息

Rinsho Ketsueki. 2022;63(3):217-223. doi: 10.11406/rinketsu.63.217.

DOI:10.11406/rinketsu.63.217
PMID:35387936
Abstract

We report a case of a 15-year-old girl who developed refractory Clostridioides difficile infection (CDI) after allogeneic bone marrow transplantation (BMT). She was treated successfully with fecal microbiota transplantation (FMT). The patient who had aplastic anemia underwent allogeneic BMT from an HLA 1-locus-mismatched unrelated donor. Four months later, she developed gastrointestinal graft-versus-host disease (GVHD), and immunosuppressive treatment improved the GVHD. However, she developed CDI 5 months after BMT and experienced recurrence after that. Fifteen months after transplant, CDI relapsed despite discontinuation of immunosuppressive treatment; thus, she underwent FMT. Colonoscopy at the time of FMT revealed round aphthae, mainly in the ileocecum, and colonic biopsy revealed inflammatory cell infiltration and noncaseating epithelioid granuloma, which fulfilled the diagnostic criteria for Crohn's disease. Following FMT for CDI, she was treated with enteric budesonide and intravenous methotrexate for Crohn's disease. These interventions resulted in a marked improvement in both CDI and Crohn's disease. Twenty-eight months after FMT, both CDI and Crohn's disease remained in remission with oral mesalamine monotherapy.

摘要

我们报告一例15岁女孩,她在异基因骨髓移植(BMT)后发生了难治性艰难梭菌感染(CDI)。她通过粪便微生物群移植(FMT)成功治愈。该再生障碍性贫血患者接受了来自一名HLA 1位点不匹配的无关供者的异基因BMT。四个月后,她出现了胃肠道移植物抗宿主病(GVHD),免疫抑制治疗改善了GVHD。然而,她在BMT后5个月发生了CDI,此后经历了复发。移植后15个月,尽管停用了免疫抑制治疗,CDI仍复发;因此,她接受了FMT。FMT时的结肠镜检查显示圆形阿弗他溃疡,主要位于回盲部,结肠活检显示炎性细胞浸润和非干酪样上皮样肉芽肿,符合克罗恩病的诊断标准。在因CDI接受FMT后,她接受了肠溶布地奈德和静脉注射甲氨蝶呤治疗克罗恩病。这些干预措施使CDI和克罗恩病均有显著改善。FMT后28个月,CDI和克罗恩病均通过口服美沙拉嗪单药治疗维持缓解。

相似文献

1
[Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient].[异基因骨髓移植受者中粪便微生物群移植治疗难治性艰难梭菌感染合并克罗恩病]
Rinsho Ketsueki. 2022;63(3):217-223. doi: 10.11406/rinketsu.63.217.
2
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
3
Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.粪菌移植治疗复发性或难治性艰难梭菌感染的长期耐久性和安全性:有无抗生素暴露的比较。
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1731-1735. doi: 10.1007/s10096-019-03602-2. Epub 2019 Jun 5.
4
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.微生物定植与粪菌移植治疗炎症性肠病和非炎症性肠病患者艰难梭菌感染的疗效。
Inflamm Bowel Dis. 2019 May 4;25(6):969-979. doi: 10.1093/ibd/izy398.
5
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.粪便微生物群移植治疗复发性肠道艰难梭菌感染 - 十年单中心经验。
Cas Lek Cesk. 2022 Summer;161(3-4):126-130.
6
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.复发性艰难梭菌感染行粪便微生物移植后的炎症性肠病结局。
Inflamm Bowel Dis. 2021 Aug 19;27(9):1371-1378. doi: 10.1093/ibd/izaa283.
7
Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Infection.与感染患者粪便微生物群移植结局相关的因素。
Gut Liver. 2021 Jan 15;15(1):61-69. doi: 10.5009/gnl20135.
8
Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.粪菌移植至孕妇后传递给婴儿的跨代细菌株转移:病例报告。
Microbiome. 2022 Nov 10;10(1):193. doi: 10.1186/s40168-022-01394-w.
9
Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.粪便微生物移植治疗实体器官移植受者复发性和严重艰难梭菌感染:一项多中心经验。
Am J Transplant. 2019 Feb;19(2):501-511. doi: 10.1111/ajt.15058. Epub 2018 Aug 31.
10
Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.早期、重复粪菌移植成功治疗严重、难治性艰难梭菌结肠炎。
Am J Health Syst Pharm. 2021 Jul 22;78(15):1374-1381. doi: 10.1093/ajhp/zxab161.

引用本文的文献

1
Fecal microbiota transplantation for Crohn's disease-like intestinal lesions arising after allogeneic stem cell transplantation.粪便微生物群移植治疗异基因干细胞移植后出现的克罗恩病样肠道病变。
Int J Hematol. 2025 Aug 28. doi: 10.1007/s12185-025-04049-2.
2
Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions.下一代益生菌与慢性病:当前研究及未来方向综述
J Agric Food Chem. 2024 Dec 18;72(50):27679-27700. doi: 10.1021/acs.jafc.4c08702. Epub 2024 Nov 26.